mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0008 |